(Q36001975)

11 August 2017

1 reference

title

Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma (English)

1 reference

11 August 2017

1 reference

1 reference

1 reference

K. K. Fields

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563705

9 October 2022

G. J. Elfenbein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563705

9 October 2022

R. A. Saleh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563705

9 October 2022

P. E. Zorsky

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563705

9 October 2022

W. E. Janssen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563705

9 October 2022

J. B. Perkins

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563705

9 October 2022

T. G. Saleh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563705

9 October 2022

J. T. Piazza

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563705

9 October 2022

L. E. Kronish

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563705

9 October 2022

M. C. Machak

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563705

9 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1563705

9 October 2022

publication date

1 January 1992

1 reference

11 August 2017

Hematological Oncology

1 reference

11 August 2017

10

1 reference

11 August 2017

61-74

1 reference

11 August 2017

1

1 reference

Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants

11 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

Autologous bone marrow transplantation. Current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

Ifosfamide--pharmacology, safety and therapeutic potential

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

Carboplatin: current status and future prospects

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

High-dose ifosfamide with mesna uroprotection: a phase I study

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

Dose: a critical factor in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

Bone marrow autotransplantation for solid tumors--prospects

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

Ifosfamide cardiotoxicity in humans

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

High-dose ifosfamide and mesna as continuous infusion over five days--a phase I/II trial

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

Twenty years of MOPP therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

Management and survival of female breast cancer: results of a national survey by the American College of Surgeons

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900100111

7 January 2021

Identifiers

DOI

10.1002/HON.2900100111

1 reference

11 August 2017

1 reference